Oncology Research and Treatment

Article	Citations
Impact of epidural anesthesia on the outcome of elderly patients with endometrial cancer – results of a propensity score matched analysis	24
Modifications to prostate cancer diagnosis following COVID-19 and following models	22
Iptacopan: Erste orale PNH-Monotherapie	20
A Population-Based and Propensity Score-Matched Investigation of the Occurrence, Management, and Prognosis of Anal Mucinous Adenocarcinoma Patients	20
ASH-Daten zu Wirksamkeit und Sicherheit von Teclistamab beim RRMM	18
Neoadjuvant Pyrotinib plus Trastuzumab, Docetaxel, and Carboplatin in Early or Locally Advanced Human Epidermal Receptor 2-Positive Breast Cancer in China: A Multicenter, Randomized, Double-Blind, Pla	15
Allogeneic Hemopoietic Cell Transplantation as a Paradigm for Cellular Immunotherapy	14
New insights from long-term clinical use of ctDNA-based minimal residual disease monitoring in translocation-associated sarcomas	13
Society Bulletins	12
Paclitaxel/Ramucirumab versus Paclitaxel in 2nd-Line Therapy of Advanced Esophageal Squamous Cell Carcinoma: Randomized Phase II IKF-AIO-RAMOS Trial	11
Interview mit Prof. Paul G. Richardson, Boston, zu Melflufen	11
Oncolytic Activity of Canine Distemper Virus in Human Ductal Breast Carcinoma Cells	11
Front & Back Matter	10
Multiples Myelom: Langzeitergebnisse der MAIA-Studie	9
Front & Back Matter	8
Front & Back Matter	8
Sacituzumab govitecan beim fortgeschrittenen Mammakarzinom	7
Society Bulletins	7
Gastroesophageal Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023	7
uGI: Biomaker-Cut-Offs in der Immunonkologie	7
Front & Back Matter	7
Oncology in Europe	6
A Case Report on Cannabinoid Hyperemesis Syndrome in Palliative Care: How Good Intentions Can Go Wrong	5
PharmaNews	5
Next-Generation Sequencing of Circulating Tumor DNA Can Optimize Second-Line Treatment in RAS Wild-Type Metastatic Colorectal Cancer after Progression on anti-EGFR Therapy: Time to Rethink Our Approac	5

Chronic Cutaneous Disorders Are Associated with a More Favorable Disease Presentation and Outcome in Patients with Hodgkin Lymphoma	5
A Prospective Study on Defining the Indications of Prophylactic Level IB Radiotherapy in Nasopharyngeal Carcinoma Based on a Risk Score Model	5
CTCL-Therapie mit Mogamulizumab	5
Five-Fraction Stereotactic Radiotherapy for Brain Metastases: A Single-Institution Experience on Different Dose Schedules	5
Zulassungserweiterung Yescarta beim r/r FL	4
Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2022	4
Medical Oncology Education in Europe: Equipping Medical Oncologists to Provide the Best Care for Patients with Cancer	4
Polypharmazie - Wechselwirkungen der BTKi	4
Das inoperable NSCLC im Stadium III im Dialog	4
Prelims	4
PD-1 Blockade Elicits Ongoing Remission in Two Cases of Refractory Microsatellite-Stable Cancer Harboring a POLE Mutation	4
Vorwort des DGHO-Vorstandes	4
A Systematic Review for Evaluation of Specialized Programs for Addressing Young Women with Breast Cancer Problems	4
Diagnostic Value of VDR in Bone Metastasis and Prognosis of Patients with Breast Cancer and Expression Correlation between Vitamin D Receptor and Hairless Protein	4
Perspectives for Cancer Care and Research in Central and Eastern Europe	4
High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Salvage Therapy of Relapsed/Refractory Germ Cell Tumors: A Single-Center Experience	3
Society Bulletins	3
PharmaNews	3
CLL: Daten bestätigen Nutzen von Venetoclax-Kombinationstherapien	3
PharmaNews	3
PharmaNews	3
Analysis of Burnout Prevalence among German Physicians Working in a Palliative Care Setting: A Survey of the AIO Quality of Life Working Group	3
Highlights of Translational and Molecular Research Presented at the European Society for Medical Oncology Annual Meeting 2023	3
Erstlinien-IO-IO-Regime: 4-Jahres-OS-Rate bei 25%	3
Assessment and Evaluation of Psychosocial Distress in Outpatients with Cancer at a University Hospital in Germany	3
High In-Hospital Mortality in SARS-CoV-2-Infected Patients with Active Cancer Disease during Omicron Phase of the Pandemic: Insights from the CORONA Germany Study	3
Identification and Validation of Cyclin A2 and Cyclin E2 as Potential Biomarkers in Small Cell Lung Cancer	3
Prelims	3
Laser Interstitial Thermal Therapy in a Large Thalamic Glioma with Long-Term Remission: A Case Report	2
PharmaNews	2
No Survival Differences among Germ-Cell Cancer Patients from Urban and Rural Areas	2
Erratum	2
Liquid Biopsy in Metastatic Breast Cancer: Current Role of Circulating Tumor Cells and Circulating Tumor DNA	2
Society Bulletins	2
Ivosidenib: Zielgerichtete Therapieoption bei IDH1-Mutationen	2
Front & Back Matter	2
Society Bulletins	2
PharmaNews	2
Society Bulletins	2
Expression of BCRP/ABCG2 Protein in Invasive Breast Cancer and Response to Neoadjuvant Chemotherapy	2
BRAF V600E Mutation in Triple-Negative Breast Cancer: A Case Report and Literature Review	2
Risk and Prognosis of Subsequent Primary Gastric Cancer	2
Mucinous Cystadenocarcinoma of the Breast with Bone Metastases: First Case Report and Literature Review	2
Front & Back Matter	2
A Multicentre, Randomized Trial in Adults with de novo Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia to Assess the Efficacy of Ponatinib versus Imatinib in Combination with Low-Intens	2
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie. 13. bis 16. Oktober 2023, Hamburg: Abstracts	2
Hypogammaglobulinemia and Anti-CD20 Therapy-Induced Acute Thrombocytopenia: Perhaps More than a Coincidence?	2
Sex-Disaggregated Analysis of Central Venous Catheter-Related Bloodstream Infections in Patients with Cancer	2
Comparative Analysis of Postoperative Complications after Cytoreductive Surgery and HIPEC in Gastric Cancer	2
Colorectal Cancer Highlights from the European Society for Medical Oncology Annual Meeting 2023	1

Front & Back Matter	1
Before-and-after studies in oncology: how real is the real-world evidence?	1
Acknowledgement to Reviewers	1
Intradermal Naked DNA Vaccination by DNA Tattooing for Mounting Tumor-Specific Immunity in Stage IV Melanoma Patients: A Phase I Clinical Trial	1
Ambulatory Routine Care in Oncology in Germany: Real-World Survival Data	1
Health Economic Aspects of Platelet Concentrates: Comparing Cost and Reimbursement of Pathogen Inactivated and Conventional Platelet Concentrates in a German Comprehensive Cancer Center	1
OnkoImmun 20	1
Durable Responses to Chemotherapy in Patients with Metastatic Soft-Tissue Sarcoma	1
Front & Back Matter	1
Transferability of Health-Related Quality of Life Data of Large Observational Studies to Clinical Practice: Comparing Retroperitoneal Sarcoma Patients from the PROSa Study to a TARPS-WG Cohort	1
ONKOPEDIA Guideline Updates “in a Nutshell” for the Readers of Oncology Research and Treatment	1
Artificial Intelligence and Gynecological Oncology: A Comparative Study of ChatGPT-Omni and Gemini-Pro Across Repeated Intervals with Case Scenario and Open-Ended Queries	1
Preliminary Clinical Validation of a Filtration-Based CTC Assay for Tumor Burden and HER2 Status Monitoring in Metastatic Breast Cancer	1
Aggressive B-Cell Lymphoma with Metastatic Spinal Cord Compression: Treat the Patient, Not the Disease	1
Geriatric Assessment Scale for Optimal Management of Gastric Cancer in Older Adults Who Underwent Gastrectomy: A Systematic Review	1
Antibody-Drug Conjugates for Breast Cancer	1
Adjuvant Treatment with S-1 in Patients after R0-Resection of Adenocarcinoma of the Stomach and Esophagogastric Junction: A Multicenter Phase I/II Feasibility Study (GMBH-STO-0114)	1
EGFR-Tyrosine Kinase Inhibitor Combined with Radiotherapy in 105 Patients of Lung Adenocarcinoma with Brain Metastasis: A Retrospective Study of Prognostic Factor Analysis	1
Significance of Patient-Reported Outcomes for Metastatic Breast Cancer Patients	1
Epidemiology, Real-World Treatment Patterns, and Patient Outcomes of Primary Advanced or Recurrent Endometrial Cancer in Germany between 2015 and 2021	1
Society Bulletins	1
36. Deutscher Krebskongress. Fortschritt gemeinsam gestalten, 21.–24. Februar 2024, Berlin: ABSTRACTS	1
Combining Poly-(ARD-Ribose) Polymerase and Programmed Cell Death Protein 1 Inhibition in a Patient with Esophagogastric Adenocarcinoma	1
Atezolizumab beim operablen NSCLC	1
PharmaNews	1
Therapiesteuerung in der Hämatologie und Onkologie	0
PharmaNews	0
PharmaNews	0
Durable Response after Olaparib Treatment for Perihilar Cholangiocarcinoma with Germline BRCA2 Mutation	0
Associations of Dietary Factors with Cutaneous Melanoma: A Case-Control Study in Greece with Literature Review	0
ASCO Annual Meeting 2022: Neue Daten zu Antikörper-Drug-Konjugaten (ADCs) und CDK4/6-Inhibitoren beim metastasierten Mammakarzinom	0
Male Breast Cancer: Therapy-Induced Toxicities, Psychological Distress, and Individual Patient Goals during Oncological Inpatient Rehabilitation	0
Prognostic Significance of HER2 Positivity in Endometrium Cancer	0
Clinicopathologic Features and Efficacy of Induction Chemotherapy in Nasopharyngeal Carcinoma: Real-World Experience	0
PharmaNews	0
PharmaNews	0
PharmaNews	0
Effektive Therapieoption: Pegcetacoplan bei PNH	0
Acknowledgement to Reviewers	0
Onkologische Patient*innen individuell behandeln und begleiten	0
PharmaNews	0
Genomic Landscape of Circulating-Tumor DNA in a Diverse Cohort of Metastatic Breast Cancer Patients	0
Sacituzumab govitecan: Zulassungserweiterung HR+/HER2– mBC	0
Society Bulletins	0
Disease Burden of Colorectal Cancer in China from 1990 to 2019: Age- and Sex-Specific Time Trends and 10-Year Forecast	0
Front & Back Matter	0
Established and Experimental Systemic Treatment Options for Advanced Liposarcoma	0
OnkoImmun 16	0
Role of Chemoradiation in the Adjuvant Treatment of Radically Resected Pancreatic Cancer Patients: A Mono-Institutional Retrospective Analysis	0
Introduction of a New Satellite Model for Participation in Clinical Trials in a Consortial Comprehensive Cancer Center with Four University Hospitals in Germany	0
Successful Liver Transplantation of Recurrent Fibrolamellar Carcinoma following Clinical and Pathologic Complete Response to Triple Immunochemotherapy: A Case Report	0
Vorteile des MAIA-Regimes bei Hochrisikozytogenetik	0
A Phase II Study of Nab-Paclitaxel and Gemcitabine as First-Line Therapy in Patients with Cholangiocarcinoma Ineligible for Cisplatin-Based Chemotherapy (NACHO)	0
Current Research Status of Metronomic Chemotherapy in Combination Treatment of Breast Cancer	0
Awareness of Human Papillomavirus (HPV) and HPV Vaccination amongst the General Population in Germany: Lack of Awareness and Need for Action	0
Expert Report on Immune Thrombocytopenia: Current Diagnostics and Treatment – Recommendations from an Expert Group from Austria, Germany, and Switzerland	0
PharmaNews	0
Acknowledgement to Reviewers	0
PharmaNews	0
Erstlinientherapie nicht-transplantationsfähiger Myelom-Patient*innen mit D-Rd	0
Society Bulletins	0
Association between Resting Heart Rate and Oncological Outcomes in Patients with Early-Stage Cervical Cancer Who Have Undergone Radical Hysterectomy with Pelvic Lymphadenectomy	0
PharmaNews	0
Prioritization and Resource Allocation in the Context of the COVID-19 Pandemic: Recommendations for Colorectal and Pancreatic Cancer in Germany	0
Bone Infarct-Associated Osteosarcoma: Epidemiologic and Survival Trends	0
Breast Cancer Patients Are at Increased Risk of Developing Uterine Serous Cancer: Implications for Counseling – A SEER Analysis	0
The Burden of Fear of Cancer Recurrence in Genitourinary Cancers: A Prospective Study (NCT04535921)	0
Management of Oligometastatic Disease in Esophagogastric Cancer: What Is the Evidence?	0
Gender as a Contextual Factor in Quality of Life of Cancer Survivors: A Literature Review	0
Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023 with Focus on Targeted Therapies	0
Empowering of Oncology Patients and Informal Caregivers: Analysis of an Interdisciplinary Seminar Model for Breast Cancer and Gyneco-Oncological Patients	0
Patterns of Care and Survival in Cancer Patients with Brain Metastases Receiving Immune Checkpoint Inhibitors	0
Neue AML-Therapie für IDH1-Mutation zugelassen	0
PharmaNews	0
Selective COX-2 Inhibitor Is Beneficial in Suppressing Chronic Postsurgical Pain in Esophageal Cancer Patients and May Prolong Patient Survival	0
Front & Back Matter	0
Expertenreport Immunthrombozytopenie – Aktuelle Diagnostik und Therapie	0
Society Bulletins	0
Front & Back Matter	0
Family Formation and Socio-Economic Status among 35-Year-Old Men Who Have Survived Cancer in Childhood and Early Adulthood: A Register-Based Cohort Study	0

Enhanced Survival with Lymphadenectomy in Early-Stage Metachronous Second Primary Lung Cancer: A Retrospective Analysis	0
PharmaNews	0
Prelims	0
New Opportunities in Advanced Breast Cancer	0
NSCLC mit EGFR-Mutation: Osimertinib mit beeindruckenden Ergebnissen	0
Erstmals 3-Jahres-Daten bei biliären Karzinomen	0
Fortgeschrittenes oder nicht resezierbares HCC: explorative 4-Jahres-Analyse STRIDE	0
First-in-Class-Therapie mit Sacituzumab Govitecan	0
Anaemia in Hospitalized Cancer Patients: A Retrospective Study of Two Cohorts before and after the Guideline Update	0
Society Bulletins	0
Highlights of Translational and Molecular Research Presented at the European Society for Medical Oncology Annual Meeting 2024	0
Therapiemanagement von Sacituzumab Govitecan	0
Pirtobrutinib: Nicht-kovalente BTKi-Therapieoption beim MCL	0
Metastases Affecting Cranial Nervous Structures in Male Breast Cancer: Two Case Reports	0
EGFR plus MET Targeted Therapies for Overcoming Treatment Resistance in EGFR-Mutant Non-Small Cell Lung Cancer: A Case Report	0
Chancen tumoragnostischer Therapieansätze	0
Exercise as Medicine Could Be a Chance for Early Detection and Prevention of Cardiotoxicity in Cancer Treatments: A Narrative Review	0
Real-World Survival Outcomes in Patients with Different Types of Cancer Managed with Immune Checkpoint Inhibitors	0
Effect of Adjuvant Chemotherapy in Stage III Cervical Cancer Patients Treated with Concurrent Chemoradiation: A Multicenter Study	0
ALL - Blinatumomab verbesserte die Prognose für Kinder	0
Impact of Geriatric Assessment on the Tolerability of Combination Chemotherapy in Older Patients with Advanced Cancer: A Matched-Pair Analysis	0
The Preventive Effects of Boron-Based Gel on Radiation Dermatitis in Patients Being Treated for Breast Cancer: A Phase III Randomized, Double-Blind, Placebo-Controlled Clinical Trial	0
The Leucine-Rich α2-Glycoprotein-1 Levels in Patients with Multiple Myeloma	0
Survivorship in Chimeric Antigen Receptor T-Cell Therapy Recipients: Infections, Secondary Malignancies, and Non-Relapse Mortality	0
Circulating Glypican-4 Is a Predictor of 24-Month Overall Survival in Metastatic Breast Cancer	0
The Study of Cerebral Blood Flow Variations during Brain Metastases Radiotherapy	0
Pan-HER Tyrosine Kinase Inhibitor Pyrotinib Enhances Radiosensitivity via ERK1/2 Pathway in HER2-Positive Gastric Cancer	0
Stereotactic Radiotherapy in Early-Stage Breast Cancer in Neoadjuvant and Exclusive Settings: A Systematic Review	0
Contents Vol. 47, 2024	0
Tumor Infiltrating Lymphocytes, CAR-, and T Cell Receptor- Modified T Cells in Solid Cancer Oncology	0
Quality of Life of Patients with Head and Neck Cancer Receiving Cetuximab, Fluorouracil, Cisplatin Comparing to Cetuximab, Fluorouracil, Cisplatin, and Docetaxel within the CEFCID Trial	0
4-Jahres-Daten der CheckMate-9LA-Studie zum NSCLC	0
NSCLC: RWE-Daten zur Sequenztherapie	0
Contents Vol. 45, 2022	0
PharmaNews	0
Stability of End-of-Life Care Wishes and Gender-Specific Characteristics of Outpatients with Advanced Cancer under Palliative Therapy: A Prospective Observational Study	0
PharmaNews	0
Resektabilität bei NSCLC III: Schlüssel zur Therapie	0
Effects of a Sound Intervention on Physical and Emotional Well-Being in Patients with Cancer: A Prospective Randomized Trial	0
Sarcoma Research with Cancer Registry Data: Data and Peculiarities of Germany in the Light of Other Countries	0
Multi-Targeting CAR-T Cell Strategies to Overcome Immune Evasion in Lymphoid and Myeloid Malignancies	0
Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023 with Focus on Perioperative Therapy, Radiotherapy, and Bispecific T-Cell Engagers	0
Stereotactic Radiotherapy for Penile Metastasis: Case Report and Systematic Literature Review	0
PharmaNews	0
Efficacy and Safety of PD-1 Immune Checkpoint Inhibitors in Locally Advanced and Advanced Non-Small-Cell Lung Cancer Patients with Chronic Infection	0
Die erste rein orale, zeitlich begrenzte CLL-Erstlinientherapie	0
PharmaNews	0
Prelims	0
Society Bulletins	0
Total Lymph Node Yield Is Associated with Prolonged Survival after Neoadjuvant Chemotherapy in ypN0 Gastric Cancer Patients	0
PharmaNews	0
PharmaNews	0
Barriers and Facilitators in Continuous Medical Education Related to Allogeneic Stem Cell Transplantation: A Qualitative Study of Physicians	0
Front & Back Matter	0
Quality Measurement for Soft Tissue Sarcomas in Germany: First Results of the Certified Sarcoma Centres	0
Key Prognostic Factors Create a Composite Risk Score to Stratify Patients into High- and Low-Treatment Benefit Groups: A Multicenter, Retrospective Data Analysis of 84 Metastatic Colorectal Cancer Pat	0
Efficacy and Safety of Bevacizumab in Pretreated Metastatic Breast Cancer: A Systematic Review and Meta-Analysis	0
Low Serological Prevalence of SARS-CoV-2 Antibodies in Cancer Patients at a German University Oncology Center	0
Transparency on Platelet Transfusion in Routine Cancer Care: The Key for Optimal Blood Usage?	0
PharmaNews	0
Treatment of Metastatic Colorectal Carcinoma with Bevacizumab in First-Line and beyond First Progression: The KORALLE Non-Interventional Cohort Study	0
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 11. bis 14. Oktober 2024, Basel	0
Incidence, Prevalence, and Real-World Treatment Patterns in Chronic Myeloid Leukemia: Results from a Population-Representative German Claims Data Analysis	0
Combination Therapy Consisting of Transarterial Chemoembolization, Lenvatinib, and Programmed Cell Death Protein 1 Blockade for Hepatocellular Carcinoma with Inferior Vena Cava Tumor Thrombus: A Case	0
r/r LBCL: CAR-T-Zelltherapie im Behandlungsalltag	0
Clinicopathological Features and Survival Trends of Non-Epithelial Ovarian Cancer: Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database	0
PharmaNews	0
The Diagnostic Utility of cfDNA and ctDNA in Liquid Biopsies for Gastrointestinal Cancers over the Last Decade	0
Identification of Biomarkers for Cervical Cancer Radiotherapy Sensitivity and Survival Prognosis	0
Curative Polyendocrine Therapy in a 21-year-Old Patient with Endometrial Carcinoma: Case Report and Review of the Literature	0
Programmed Cell Death Protein 1 Blockade Elicits Ongoing Remission in 2 Cases of Refractory Epstein-Barr Virus-Associated Metastatic Gastric Carcinoma	0
Clinical Impact of Structured Post-Operative Surveillance in Resected Pancreatic Adenocarcinoma: Results from a Retrospective Cohort Study	0
Epcoritamab: Indikationserweiterung für das FL	0
AGSMO Jahreskongress 2023 - Abstracts	0
PARANEOPLASTIC PAPILLITIS AS A PRECURSOR TO COLON CARCINOMA. A CASE OF UNEXPECTED VISION LOSS LEADING TO EARLY CANCER DETECTION	0
A Prospectivly Randomized Phase-II Trial of Axitinib versus Everolimus as Second-Line Therapy in Metastatic Renal Cell Carcinoma (BERAT Study)	0
Chemoimmuntherapie als ein Standard bei ED-SCLC	0
Prelims	0
Capivasertib + Fulvestrant beim metastasierten Brustkrebs	0
A Panel of Three Serum MicroRNAs as a Potential Diagnostic Biomarker for Urothelial Carcinoma	0
Pancreatic Ductal Adenocarcinoma: New Insights into the Actions of Vitamin A	0
BTKi: die Entwicklung geht weiter	0
AbbVie: BioPharma-Unternehmen mit onkologischer Mission	0
PharmaNews	0
Management of Aortoesophageal Fistula in a Palliative Patient with Non-Small-Cell Lung Cancer: A Case Report	0
Society Bulletins	0
Momelotinib bei Myelofibrose und Anämie	0
Society Bulletins	0
Evaluating the benefits and challenges of using patient preferences as a tool for clinical decision making in oncology MDT meetings within the National Health Service (NHS): A qualitative study	0
Navigating Gynecological Oncology with Different Versions of ChatGPT: A Transformative Breakthrough or the Next Black Box Challenge?	0
Vorwort des DGHO-Vorstands	0
Durvalumab auch bei Hirnmetastasen vorteilhaft	0
Effect of Early Tumor Shrinkage and Depth of Response on the Clinical Outcomes of Patients with Unresectable Hepatocellular Carcinoma Treated with Transcatheter Arterial Chemoembolization and Lenvatin	0
Psycho-Oncological Self-Help Groups in Bavaria: The Current Situation and Suggestions for Improvement	0
PharmaNews	0